- Pharmaceutical companies
- Africa
- Ghana
- Novartis
Novartis in Ghana
Addresses:
-
Novartis Pharma Services AG, Ghana Representativ Office, Le Pierre 3rd floor, 14 Senchi Street, Airport Residential Area Plot No. 76A, GH- Accra, Ghana
-
SANDOZ d.d., Anysia Building, No. 17 Ringway Estates, Osu, Accra, Ghana
Phone: 233 577 66 6766
Fax: 233 577 66 6768
Other Novartis's locations around the world
-
Switzerland
-
Austria
-
Germany
-
Slovenia
-
Poland
-
France
-
Spain
-
Belgium
-
Romania
-
Italy
-
United Kingdom
-
Ukraine
-
Russia
-
Serbia
-
Slovakia
-
Sweden
-
Belarus
-
Bulgaria
-
Croatia
-
Czech Republic
-
Denmark
-
Estonia
-
Finland
-
Greece
-
Hungary
-
Iceland
-
Ireland
-
Latvia
-
Lithuania
-
Luxembourg
-
Macedonia
-
Malta
-
Montenegro
-
Netherlands
-
Norway
-
Portugal
-
Albania
-
Bosnia & Herzegovina
Clinical Trials sponsored by Novartis
-
Novartis PharmaceuticalsAún no reclutandoEsclerosis Múltiple Recurrente-Remitente
-
Novartis PharmaceuticalsAún no reclutandoArtritis Reumatoide | Lupus eritematoso sistémico | Enfermedad de Sjögrens
-
Novartis PharmaceuticalsAún no reclutandoLp(a) elevada y enfermedad cardiovascular aterosclerótica establecida
-
Novartis PharmaceuticalsReclutamientoFormas recurrentes de esclerosis múltipleEspaña
-
Novartis PharmaceuticalsReclutamiento
-
Novartis PharmaceuticalsAún no reclutando
-
Novartis PharmaceuticalsReclutamientoEsclerosis múltiple (EM)Francia
-
Novartis PharmaceuticalsAún no reclutando
-
Novartis PharmaceuticalsReclutamiento
-
Novartis PharmaceuticalsReclutamientoEnfermedad coronaria | Hematopoyesis clonal de potencial indeterminado (CHIP)Alemania, Canadá
About Novartis
Novartis is structured to deliver innovative products, exploit global scale, and respond to new opportunities and risks. Our purpose is to reimagine medicine to improve and extend people's lives. We use innovative science and technology to address some of society's most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. We also aim to reward those who invest their money, time and ideas in our company.